Subscribe
27 February 2025NewsEuropeIona Silverman, Freeths

The rise of weight loss drugs: Regulators tighten up

Concerns over misuse, side effects and counterfeits are tightening controls on the blockbuster treatments, says Iona Silverman of Freeths.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Fed Circ’s Wuhan v ITC ruling opens ITC door to small corps
25 February 2025   Smaller US companies can now choose to take on much larger, foreign opponents at the ITC, explain Cristen Corry, Paul Ainsworth and Uma Everett of Sterne Kessler.
Big Pharma
Ozempic counterfeits prompt Novo Nordisk to join forces with authorities
12 March 2024   Danish drugmaker testing suspect products and assisting with legal cases | High demand and global shortages have driven surge in weight-loss drug fakes.


Editor's picks

Europe
‘It’s business as usual’: ERS Genomics enjoys new EPO patent after CRISPR gambit pays off
27 February 2025

Editor's picks

Europe
‘It’s business as usual’: ERS Genomics enjoys new EPO patent after CRISPR gambit pays off
27 February 2025
Americas
Regeneron holds off copies of $6bn eye treatment
4 February 2025
Careers
Bristows appoints Irish patent attorney to boost UPC representation
4 February 2025
Americas
New national rankings recognise top US patent firms and lawyers
4 February 2025
Europe
UK court upholds EU SPC precedent, rejecting MSD’s appeal
30 January 2025
Americas
ADCs, TCR, and multimodal AI: Transformative trends in 2025
23 January 2025

More on this story

Americas
Fed Circ’s Wuhan v ITC ruling opens ITC door to small corps
25 February 2025   Smaller US companies can now choose to take on much larger, foreign opponents at the ITC, explain Cristen Corry, Paul Ainsworth and Uma Everett of Sterne Kessler.
Big Pharma
Ozempic counterfeits prompt Novo Nordisk to join forces with authorities
12 March 2024   Danish drugmaker testing suspect products and assisting with legal cases | High demand and global shortages have driven surge in weight-loss drug fakes.

More on this story

Americas
Fed Circ’s Wuhan v ITC ruling opens ITC door to small corps
25 February 2025   Smaller US companies can now choose to take on much larger, foreign opponents at the ITC, explain Cristen Corry, Paul Ainsworth and Uma Everett of Sterne Kessler.
Big Pharma
Ozempic counterfeits prompt Novo Nordisk to join forces with authorities
12 March 2024   Danish drugmaker testing suspect products and assisting with legal cases | High demand and global shortages have driven surge in weight-loss drug fakes.

More features

‘It’s business as usual’: ERS Genomics enjoys new EPO patent after CRISPR gambit pays off
Abbott v Sibio: A game-changer for UPC tech disputes
Paul Hastings adds Latham tech transactions expert as co-chair
Why Abbott’s victory marks a turning point for UPC preliminary injunctions
Natera loses $96m jury win as judge invalidates DNA test patents
Fed Circ’s Wuhan v ITC ruling opens ITC door to small corps
Hikma warns SCOTUS of ‘imminent threat’ for generic competition under ‘skinny label’ rules
Gilead deal staves off generic HIV drugs for another six years